1. Rauck RL, Naveira F, Speight KL, Smith BP. Refractory idiopathic erythromelalgia. Anesth Analg. 1996; 82:1097–1101. PMID:
8610879.
Article
2. Galimberti D, Pontón A, Rubio L, Torre A, Angles V, Soriano E, et al. A case of primary erythromelalgia. J Eur Acad Dermatol Venereol. 2009; 23:1338–1339. PMID:
19368608.
Article
3. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000; 43:841–847. PMID:
11050591.
Article
4. Park SK, Han KR, Lee YS, Hyun HS, Kim C. Epidural block of bupivacaine and mexiletine for erythromelalgia. Korean J Anesthesiol. 2001; 41:792–795.
Article
5. Stricker LJ, Green CR. Resolution of refractory symptoms of secondary erythermalgia with intermittent epidural bupivacaine. Reg Anesth Pain Med. 2001; 26:488–490. PMID:
11561273.
Article
6. D'Angelo R, Cohen IT, Brandom BW. Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent. Anesth Analg. 1992; 74:142–144. PMID:
1734777.
7. Waxman SG, Dib-Hajj SD. Erythromelalgia: a hereditary pain syndrome enters the molecular era. Ann Neurol. 2005; 57:785–788. PMID:
15929046.
Article
8. Dib-Hajj SD, Rush AM, Cummins TR, Hisama FM, Novella S, Tyrrell L, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005; 128:1847–1854. PMID:
15958509.
Article
9. Natkunarajah J, Atherton D, Elmslie F, Mansour S, Mortimer P. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. Clin Exp Dermatol. 2009; 34:E640–E642. PMID:
19549232.
10. Nathan A, Rose JB, Guite JW, Hehir D, Milovcich K. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. Pediatrics. 2005; 115:E504–E507. PMID:
15741349.
Article
11. Davis MD, O'Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000; 136:330–336. PMID:
10724194.
12. Rudikoff D, Jaffe IA. Erythromelalgia: response to serotonin reuptake inhibitors. J Am Acad Dermatol. 1997; 37:281–283. PMID:
9270523.
Article
13. Harrison CM, Goddard JM, Rittey CD. The use of regional anaesthetic blockade in a child with recurrent erythromelalgia. Arch Dis Child. 2003; 88:65–66. PMID:
12495966.
Article
14. Weinstein SM, Herring SA. Lumbar epidural steroid injections. Spine J. 2003; 3(3 Suppl):37–44.
Article
15. Seishima M, Kanoh H, Izumi T, Niwa M, Matsuzaki Y, Takasu A, et al. A refractory case of secondary erythermalgia successfully treated with lumbar sympathetic ganglion block. Br J Dermatol. 2000; 143:868–872. PMID:
11069475.
Article
16. Shiga T, Sakamoto A, Koizumi K, Ogawa R. Endoscopic thoracic sympathectomy for primary erythromelalgia in the upper extremities. Anesth Analg. 1999; 88:865–866. PMID:
10195539.
Article
17. Belch JL. Lowe GD, Tooke JE, editors. Temperature-associated vascular disorder-Raynaud's phonomenon and erythromelagia. A textbook of vascular medicine. 1996. London: Oxford University Press;p. 339–352.
18. Littleford RC, Khan F, Belch JJ. Skin perfusion in patients with erythromelalgia. Eur J Clin Invest. 1999; 29:588–593. PMID:
10411664.
Article
19. Orstavik K, Mørk C, Kvernebo K, Jørum E. Pain in primary erythromelalgia-a neuropathic component? Pain. 2004; 110:531–538. PMID:
15288393.
Article